摘要
目的:研究碳酸镧联合低钙透析在维持性血液透析并发高磷高钙血症患者中的作用。方法:观察50例维持性血液透析并发高磷高钙血症患者进行药物治疗的疗效。结果:治疗后1、3、6个月,两组的血磷(P)、血甲状旁腺素(iPTH)均下降,其中观察组相关水平均较对照组低,下降程度较对照组明显,两组差异有统计学意义(P<0.05)。结论:碳酸镧联合低钙透析是一种科学的治疗方案,对维持性血液透析并发高磷高钙血症患者高磷、高钙控制安全有效。
Purpose:The role of barium carbonate combined with low calcium dialysis in maintenance hemodialysis patients with hyperphosphatemia and hypercalcemia was studied.Method:50 patients with maintenance hemodialysis complicated with hyperphosphatemia and hypercalcemia were observed for drug treatment.Result:At 1,2 and 6 months after treatment,serum phosphorus(P),blood-borne parathyroid hormone(iPTH)levels decreased in the two groups.The observation group related to the level of the control group was lower and the degree of decline was lower.In the control group,the difference between the two groups was statistically significant(P<0.05).Conclusion:Bismuth carbonate combined with low-calcium dialysis is a scientific treatment plan.It is safe and effective for hyperphosphatemia and hypercalcemia control in maintenance hemodialysis patients with hyperphosphatemia and hypercalcemia.
出处
《湖南中医药大学学报》
CAS
2018年第A01期1016-1017,共2页
Journal of Hunan University of Chinese Medicine
关键词
维持性血液透析并发高磷高钙血症
碳酸镧
低钙透析
Maintenance hemodialysis complicated by hyperphosphatemia and hypercalcemia
strontium carbonate
low calcium dialysis
